Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice

Experimental Gerontology

Volumn 46, Issue 1, 2011, Pages 43-52

  Halade, Ganesh V ^a   El Jamali, Amina ^a   Williams, Paul J ^a   Fajardo, Roberto J ^a   Fernandes, Gabriel ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Adipocytes; Aging; Bone marrow adiposity; Obesity; Osteoporosis; Visceral fat

Indexed keywords

CATHEPSIN K; CORN OIL; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE MARROW; CONTROLLED STUDY; DIET; DOWN REGULATION; EX VIVO STUDY; FEMALE; INFLAMMATION; INTRAABDOMINAL FAT; METAPHYSIS; MOUSE; NONHUMAN; OBESITY; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; TRABECULAR BONE; UPREGULATION;

ADIPOCYTES; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE MARROW; BONE RESORPTION; CORN OIL; DIETARY FATS; FEMALE; FEMUR; GENE EXPRESSION; INTRA-ABDOMINAL FAT; MICE; MICE, INBRED C57BL; OBESITY; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; PPAR GAMMA; RANK LIGAND;

MUS; ZEA MAYS;

EID: 78649828932     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.09.014     Document Type: Article

References (61)

1. Bai Y.D., Yang F.S., Xuan K., Bai Y.X., Wu B.L. Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment. Med. Hypotheses 2008, 71:256-258.
2. Bonewald L.F., Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 2008, 42:606-615.
3. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
4. Bromme D., Lecaille F. Cathepsin K inhibitors for osteoporosis and potential off-target effects. Expert Opin. Investig. Drugs 2009, 18:585-600.
5. Cao J., Venton L., Sakata T., Halloran B.P. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J. Bone Miner. Res. 2003, 18:270-277.
6. Cao J.J., Gregoire B.R., Gao H. High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. Bone 2009, 44:1097-1104.
7. Cao J.J., Sun L., Gao H. Diet-induced obesity alters bone remodeling leading to decreased femoral trabecular bone mass in mice. Ann. NY Acad. Sci. 2010, 1192:292-297.
8. Chen H., Zhou X., Emura S., Shoumura S. Site-specific bone loss in senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis. Exp. Gerontol. 2009, 44:792-798.
9. David V., Martin A., Lafage-Proust M.H., Malaval L., Peyroche S., Jones D.B., Vico L., Guignandon A. Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis. Endocrinology 2007, 148:2553-2562.
10. Deaton D.N., Tavares F.X. Design of cathepsin K inhibitors for osteoporosis. Curr. Top. Med. Chem. 2005, 5:1639-1675.
11. Dimitri P., Wales J., Bishop N. Fat and Bone in Children - Differential Effects of Obesity on Bone Size and Mass According to Fracture History. J. Bone Miner. Res. 2010, 25:527-536.
12. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
13. Duque G. Bone and fat connection in aging bone. Curr. Opin. Rheumatol. 2008, 20:429-434.
14. Duque G., Troen B.R. Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome. J. Am. Geriatr. Soc. 2008, 56:935-941.
15. Ehrlich P.J., Lanyon L.E. Mechanical strain and bone cell function: a review. Osteoporos. Int. 2002, 13:688-700.
16. El Jamali A., Valente A.J., Lechleiter J.D., Gamez M.J., Pearson D.W., Nauseef W.M., Clark R.A. Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl. Free Radic. Biol. Med. 2008, 44:868-881.
17. Feng X. Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene 2005, 350:1-13.
18. Gilsanz V., Chalfant J., Mo A.O., Lee D.C., Dorey F.J., Mittelman S.D. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J. Clin. Endocrinol. Metab. 2009, 94:3387-3393.
19. Glatt V., Canalis E., Stadmeyer L., Bouxsein M.L. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J. Bone Miner. Res. 2007, 22:1197-1207.
20. Grey A. Thiazolidinedione-induced skeletal fragility-mechanisms and implications. Diab. Obes. Metab. 2009, 11:275-284.
21. Halade G.V., Rahman M.M., Williams P.J., Fernandes G. High fat diet-induced animal model of age-associated obesity and osteoporosis. J. Nutr. Biochem. 2010, 21:1162-1169.
22. Horowitz M.C., Xi Y., Wilson K., Kacena M.A. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev. 2001, 12:9-18.
23. Kawai, M., Rosen, C.J., 2010. Bone: adiposity and bone accrual-still an established paradigm? Nat Rev Endocrinol 6, 63-4.
24. Kawai M., Devlin M.J., Rosen C.J. Fat targets for skeletal health. Nat. Rev. Rheumatol. 2009, 5:365-372.
25. Key L.L., Wolf W.C., Gundberg C.M., Ries W.L. Superoxide and bone resorption. Bone 1994, 15:431-436.
26. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001, 142:5050-5055.
27. Kirchengast S., Knogler W., Hauser G. Protective effect of moderate overweight on bone density of the hip joint in elderly and old Austrians. Anthropol. Anz. 2002, 60:187-197.
28. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
29. Kuk J.L., Saunders T.J., Davidson L.E., Ross R. Age-related changes in total and regional fat distribution. Ageing Res. Rev. 2009, 8:339-348.
30. Kyung T.W., Lee J.E., Phan T.V., Yu R., Choi H.S. Osteoclastogenesis by bone marrow-derived macrophages is enhanced in obese mice. J. Nutr. 2009, 139:502-506.
31. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., Kim N., Lee S.Y. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106:852-859.
32. Maor G., Rochwerger M., Segev Y., Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J. Bone Miner. Res. 2002, 17:1034-1043.
33. McTigue K.M., Hess R., Ziouras J. Obesity in older adults: a systematic review of the evidence for diagnosis and treatment. Obes. Silver Spring 2006, 14:1485-1497.
34. Mundy G.R. Osteoporosis and inflammation. Nutr. Rev. 2007, 65:S147-S151.
35. Naveiras O., Nardi V., Wenzel P.L., Hauschka P.V., Fahey F., Daley G.Q. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009, 460:259-263.
36. Niu T., Rosen C.J. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 2005, 361:38-56.
37. Nunez N.P., Carpenter C.L., Perkins S.N., Berrigan D., Jaque S.V., Ingles S.A., Bernstein L., Forman M.R., Barrett J.C., Hursting S.D. Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obes. Silver Spring 2007, 15:1980-1987.
38. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
39. Oh S.R., Sul O.J., Kim Y.Y., Kim H.J., Yu R., Suh J.H., Choi H.S. Saturated fatty acids enhance osteoclast survival. J. Lipid Res. 2010, 51:892-899.
40. Oyajobi B.O., Franchin G., Williams P.J., Pulkrabek D., Gupta A., Munoz S., Grubbs B., Zhao M., Chen D., Sherry B., Mundy G.R. Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease. Blood 2003, 102:311-319.
41. Patsch, J.M., Kiefer, F.W., Varga, P., Pail, P., Rauner, M., Stupphann, D., Resch, H., Moser, D., Zysset, P.K., Stulnig, T.M., Pietschmann, P., in press. Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metabolism. doi:10.1016/j.metabol.2009.11.023.
42. Petit M.A., Paudel M.L., Taylor B.C., Hughes J.M., Strotmeyer E.S., Schwartz A.V., Cauley J.A., Zmuda J.M., Hoffman A.R., Ensrud K.E. Bone Mass and Strength in Older Men with Type 2 Diabetes: The Osteoporotic Fractures in Men Study. J. Bone Miner. Res. 2010, 25:285-291.
43. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
44. Powell K. Obesity: the two faces of fat. Nature 2007, 447:525-527.
45. Premaor, M.O., Pilbrow, L., Tonkin, C., Parker, R., Compston, J., 2010. Obesity and Fractures in Postmenopausal Women. J. Bone. Miner. Res. 25, 292-297.
46. Rosen C.J. Bone remodeling, energy metabolism, and the molecular clock. Cell Metab. 2008, 7:7-10.
47. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat. Clin. Pract. Rheumatol. 2006, 2:35-43.
48. Russell, M., Mendes, N., Miller, K.K., Rosen, C.J., Lee, H., Klibanski, A., Misra, M., 2010. Visceral Fat Is a Negative Predictor of Bone Density Measures in Obese Adolescent Girls. J. Clin. Endocrinol. Metab. 95, 1247-1255.
49. Sasaki H., Yamamoto H., Tominaga K., Masuda K., Kawai T., Teshima-Kondo S., Matsuno K., Yabe-Nishimura C., Rokutan K. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues. Free Radic. Biol. Med. 2009, 47:189-199.
50. Shevde N.K., Plum L.A., Clagett-Dame M., Yamamoto H., Pike J.W., DeLuca H.F. A potent analog of 1alpha, 25-dihydroxyvitamin D3 selectively induces bone formation. Proc. Natl Acad. Sci. USA 2002, 99:13487-13491.
51. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 2006, 60:502-507.
52. Sowers, M.R., Karvonen-Gutierrez, C.A., 2010. The evolving role of obesity in knee osteoarthritis. Curr. Opin. Rheumatol. 22, 533-7.
53. Taes Y.E., Lapauw B., Vanbillemont G., Bogaert V., De Bacquer D., Zmierczak H., Goemaere S., Kaufman J.M. Fat mass is negatively associated with cortical bone size in young healthy male siblings. J. Clin. Endocrinol. Metab. 2009, 94:2325-2331.
54. Takada I., Kouzmenko A.P., Kato S. Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies. Expert Opin. Ther. Targets 2009, 13:593-603.
55. Villareal D.T., Apovian C.M., Kushner R.F., Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am. J. Clin. Nutr. 2005, 82:923-934.
56. Wardlaw G.M. Putting body weight and osteoporosis into perspective. Am. J. Clin. Nutr. 1996, 63:433S-436S.
57. Wauquier F., Leotoing L., Coxam V., Guicheux J., Wittrant Y. Oxidative stress in bone remodelling and disease. Trends Mol. Med. 2009, 15:468-477.
58. Wu D., Ren Z., Pae M., Guo W., Cui X., Merrill A.H., Meydani S.N. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J. Immunol. 2007, 179:4829-4839.
59. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl Acad. Sci. USA 1998, 95:3597-3602.
60. Yoneda T., Williams P., Rhine C., Boyce B.F., Dunstan C., Mundy G.R. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer. Cancer Res. 1995, 55:1989-1993.
61. Zhao L.J., Jiang H., Papasian C.J., Maulik D., Drees B., Hamilton J., Deng H.W. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J. Bone Miner. Res. 2008, 23:17-29.